Company Overview and News

0
IPCA Laboratories Limited - Shareholders meeting

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IPCALAB 524494

0
IPCA Laboratories Limited - Book Closure

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IPCALAB 524494

0
IPCA Laboratories Limited - Allotment of ESOP/ESPS

2018-05-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IPCALAB 524494

0
IPCA Laboratories Limited - Dividend

2018-05-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IPCALAB 524494

0
IPCA Laboratories Limited - Financial Result Updates

2018-05-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IPCALAB 524494

23
Market Live: Sensex rangebound, PSU Bank index loses 2%; BHEL up 9% on Q4 nos

2018-05-29 moneycontrol
Market Update: Benchmark indices as well as broader markets are in a consolidation mode after sharp rally seen in previous three consecutive sessions. Investors closely monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 STAR RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 538835 BHEL 539207 532531 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 BRHTY INTELLECT 500103 RECLTD MANPASAND ADFFOODS

20
Market Live: Nifty reclaims 10,700 amid weaker rupee; Vista Pharma up 10%

2018-05-29 moneycontrol
Market Update: The market continued to consolidate after rallying sharply in previous three consecutive sessions. Investors keenly monitor the movement in crude oil prices and rupee.
500325 AUROPHARMA RELIANCE 532955 532712 533106 RCOM OIL RIGD 519183 GREENPLY HDFCBANK RLNIY IPCALAB 524804 IBN 539207 ICICIBANK 524494 HDB 532174 500180 ARBQY 526797 RECLTD MANPASAND ADFFOODS

10
Market Live: Sensex, Nifty consolidate after 3-day rally; weaker rupee lifts IT stocks

2018-05-29 moneycontrol
Buzzing: After being locked in lower circuit on Monday, shares of Manpasand Beverages continued to be locked in the same band today as well, as investors continued to be wary of corporate developments. This is despite the company trying to allay fears around the controversy surrounding its auditor, Deloitte, resigning abruptly.
IPCALAB AUROPHARMA 524804 532955 532712 539207 533106 RCOM 524494 OIL HDB 500180 ARBQY 519183 526797 GREENPLY HDFCBANK RECLTD MANPASAND ADFFOODS

7
BHEL, BEL, Coal India, BPCL, IOB results eyed

2018-05-28 thehindubusinessline
Apollo Microsystems, Asahi Songwon Colours, Ashoka Buildcon, Balmer Lawrie, Bedmutha, BEL, BHEL, BPCL, Coal India, Cochin Minerals, Datamatics, Deccan Cement, Dish TV, D-Link India, Force Motors, Galaxy Surfactants, Glenmark Pharma, IOB, Ipca Laboratories, Jyothi, M&M, Max India, MMTC, Parsvanath, Sundram Brake, Thomas Cook, TTK Health, Unichem Labs, Uttam Sugar and Zenith Exports are some of the companies that will declare their Q4/FY results on Tuesday.
IPCALAB 500413 523319 533271 FORCEMOT BALMLAWRIE ASHOKA ZENITHEXPO 533278 THOMASCOOK 512553 500271 524494 MAX CLNDY COALINDIA 500033 MXGQY

0
IPCA Laboratories Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
IPCALAB 524494

40
Market Live: Sensex trades lower; SBI, ICICI drag but RIL, HDFC Bank support

2018-03-22 moneycontrol
2:58 pm Land Allotment: Emami Paper Mills said the company has been allotted 4,00,387.05 square meters of land in Sayakha Industrial Estate, District Bharuch, Gujarat, by Gujarat Industrial Development Corporation (GIDC) for greenfield expansion project for manufacturing of paper boards.
AIAENG 500325 GENUSPOWER 532839 532712 DISHTV 530343 532683 RCOM 532121 533208 534816 500570 EICHERMOT RLNIY SBAZ RELEY AXB RELFF HIN AXBA EMAMIPAP 524494 500180 RIFA 500185 AAGGY WABAG 524715 BHRYY RIFS RELIANCE 532215 500390 505200 532187 AXISBANK RIGD INFRATEL HDFCBANK TATAMOTORS HCC ECQRY IPCALAB VDTH INDUSINDBK IBN VTUWY 533269 AXBKY RELINFRA ICICIBANK HDB 532174 SUNPHARMA DENABANK TTM

32
Market Live: Sensex off day#39;s high, Nifty below 10,200; OMCs, banks under pressure

2018-03-22 moneycontrol
12:05 pm Market Update: Benchmark indices erased gains in noon, with the Sensex falling 20.11 points to 33,116.07 and the Nifty declining 6.40 points to 10,148.90.
524715 BHRYY 500325 GENUSPOWER 532839 RELIANCE 532712 532215 DISHTV 530343 505200 532121 RCOM AXISBANK 534816 RIGD INFRATEL 500570 TATAMOTORS EICHERMOT HCC RLNIY SBAZ ECQRY IPCALAB VDTH AXB IBN HIN VTUWY 533269 AXBKY AXBA ICICIBANK 524494 532174 SUNPHARMA 500185 DENABANK WABAG TTM

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

5h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...